| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.15 | 6e-07 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.28 | 9e-07 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.25 | 1e-06 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-06 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-06 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.14 | 3e-06 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.14 | 3e-06 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.27 | 3e-06 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.17 | 4e-06 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-06 |